Abstract | BACKGROUND: The success of treatment using monoclonal antibodies in oncology is influenced by, among other factors, the level of target antigen expression on tumor cells. The authors analyzed the intensity of the CD52 antigen expression in patients with chronic lymphoproliferative diseases and compared them with B-lymphocytes of a healthy population and CD34(+) cells in peripheral blood stem cells (PBSC) grafts. METHODS: RESULTS: In the group of patients with B-CLL, the CD52 level on tumor cells (245 x 10(3) MESF; 107 x 10(3) ABC) was significantly lower than on B-lymphocytes of the control group (446 x 10(3) MESF; 194 x 10(3) ABC; P < 0.001) and SLL tumor cells (526 x 10(3) MESF; 229 x 10(3) ABC; P < 0.001). The CD52 antigen was expressed on a majority of CD34(+) cells, but its expression intensity was low (101 x 10(3) MESF; 44 x 10(3) ABC). CONCLUSIONS: Our data demonstrate differences in the intensity of the CD52 antigen expression between B-lymphocytes and tumor lymphocytes of B-CLL patients, and between B-CLL and SLL tumor cells. CD52 antigen is expressed at low level on CD34(+) cells.
|
Authors | Martin Klabusay, Vera Sukova, Petr Coupek, Yvona Brychtova, Jiri Mayer |
Journal | Cytometry. Part B, Clinical cytometry
(Cytometry B Clin Cytom)
Vol. 72
Issue 5
Pg. 363-70
(Sep 2007)
ISSN: 1552-4949 [Print] United States |
PMID | 17428002
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2007 Clinical Cytometry Society. |
Chemical References |
- Antibodies, Monoclonal
- Antigens, CD
- Antigens, CD34
- Antigens, Neoplasm
- Biomarkers
- Biomarkers, Tumor
- CD52 Antigen
- CD52 protein, human
- Glycoproteins
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal
(immunology)
- Antigens, CD
(analysis, immunology, metabolism)
- Antigens, CD34
(biosynthesis)
- Antigens, Neoplasm
(analysis, immunology, metabolism)
- B-Lymphocytes
(immunology)
- Biomarkers
(analysis)
- Biomarkers, Tumor
(analysis, immunology)
- CD52 Antigen
- Chronic Disease
- Female
- Flow Cytometry
(methods)
- Glycoproteins
(analysis, immunology, metabolism)
- Hematopoietic Stem Cells
(immunology)
- Humans
- Leukemia, B-Cell
(blood, diagnosis, immunology)
- Leukemia, Lymphocytic, Chronic, B-Cell
(blood, diagnosis, immunology)
- Lymphocyte Activation
(immunology)
- Lymphoma, Mantle-Cell
(blood, diagnosis, immunology)
- Lymphoproliferative Disorders
(blood, diagnosis, immunology)
- Male
- Middle Aged
- Predictive Value of Tests
|